near-infrared light therapy

Light you can't see, reaching tissue surface light never touches.

Near-infrared light therapy — photobiomodulation — works in a narrow band your body lets through: too long for your skin to soak up, too short for the water in your tissue to stop. In that window, light at 600–1100nm reaches the mitochondria centimeters down and drives cellular energy production. Consumer panels run low irradiance and stop at the skin. Clinical-grade devices push enough power through to reach the tissue underneath: muscle, joint, bone, and brain.

Deep-tissue nir at 820nm, 850+ mW/cm² — the wavelength sits squarely on the absorption peak of cytochrome c oxidase, the enzyme inside your mitochondria that turns the light into ATP. The irradiance is high enough to carry the light centimeters into tissue, reaching muscle, joint, and bone that surface-level panels can't touch. Transcranial work uses 810nm — the most-studied wavelength for brain applications.

People with localized inflammation, joint or musculoskeletal pain, soft-tissue injury or post-training recovery, and — with transcranial 810nm — neurological work including TBI, depression, and cognitive performance. The full list is on the treatment and performance pages.

That’s a judgment you get to make once you understand it — so here’s more than a yes. This is the non-ultraviolet half of sunlight, the part you feel as warmth; it can’t sunburn you. The honest risk is overheating, and you feel that coming, because it’s heat — heat is the built-in alarm. The power means a few minutes does what ten times as long would on a weak panel, so distance and time are set for you, well short of the limit. One rule: don’t stare into the panel. The full picture — mechanism, depth, and the heat math — is on the science page.

Often paired with hyperbaric oxygen therapy — different physics, converging biology.